trial
as of 2026-07-01Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
NCTId NCT00554840
at a glance
Phase 2 · Completed
Enrollment 16 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2010-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
16 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2007-11
Primary completion
2010-12
Eligibility
ALL · 18 Years · 64 Years
Interventions & indications
Sponsors
University of Maryland, Baltimore CountyLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator
Investigators
1
Elaine Weiner, M.D.Principal Investigator
Sites
0 total
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
16
Phase
PHASE2
Primary Completion Date
2010-12
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person